Leah Lawrence

A network meta-analysis compared GLP-1 receptor agonists to traditional anti-diabetes drugs based on hypoglycemia incidence, HbA1c goals, and more.

Can adding a GLP-1 receptor agonist to lifestyle changes improve obstructive sleep apnea management in your patients?

Unlike typical Western patients, type 2 diabetes patients in Asia tend to have lower BMIs. Does this mean responses to GLP-1 RAs differ as well?

Which GLP-1 receptor agonist showed improved HbAlc with no weight gain or hypoglycemia?

Is thyroid cancer the exception to the rule that alcohol consumption is linked to an increased risk of developing cancer?

Researchers study whether or not GLP-1 affects pancreatic amylase or lipase plasma concentrations.

Not all patients with type 2 diabetes respond equally to GLP-1 receptor agonists. Results of a recent study suggest what to look for before you write that next Rx.

Pre-surgical weight loss in obese patients with type 2 diabetes reduces perioperative risk. The dual benefits of GLP-1 agonists offer promise to this hard-to-treat population.

The investigational LX4211 may one day fill a need for these patients who are unable to eliminate a lot of glucose in urine and who respond poorly to selective SGLT2 inhibitors.